Clear cell lung cancer

Clear describes how tumour cells look under a microscope; it does not by itself identify the cancer's origin. A clear cell tumour in the lung may represent a primary lung cancer with clear cell features or cancer that spread from another organ, so treatment should wait for careful classification when clinically feasible.

A pathologist examines biopsy tissue, the cells' architecture and protein markers. The team compares those findings with scans and any previous cancer history. Additional molecular testing may identify tumour changes that help classify the cancer or guide a medicine choice.

The stage records the tumour's extent, including lymph nodes and distant sites. Both origin and stage matter: a primary lung cancer and a cancer that has travelled to the lung are managed according to different disease pathways even when their cells look similar.

Ask for the exact pathology wording and whether the report identifies a lung primary. The team may review the specimen, complete imaging, assess breathing and general fitness, and request tumour profiling before recommending care.

Treatment can include surgery for a suitably located cancer that can be removed, radiotherapy to a defined area, systemic treatment such as chemotherapy, or a combination. The plan depends on the confirmed cancer type, extent, molecular findings, symptoms and your priorities. Supportive and palliative care can be provided alongside cancer-directed treatment to control breathlessness, pain, cough and fatigue.

Seek urgent assessment for sudden or severe breathlessness, chest pain, coughing up more than streaks of blood, fainting, new weakness on one side, a seizure, or new confusion. These symptoms can have several causes, but they need prompt evaluation regardless of the cancer's subtype.

Report a worsening cough, persistent hoarseness, increasing breathlessness, uncontrolled pain, reduced eating or new neurological symptoms to the cancer team without waiting for a routine visit. The team can check for treatment effects, infection, fluid around the lung or disease-related complications.

Ask whether the tumour is confirmed to have started in the lung, which stains or molecular results support that conclusion, what the stage is, and whether more tissue is needed. Request a clear explanation of each treatment's goal, likely side effects and how response will be monitored.